Purpose-built for physicians GLP-1 prescription less likely for smokers despite having more indications than nonsmokers Key takeaways: Data from a single primary care clinic showed a higher proportion of smokers were eligible to receive a GLP-1 than nonsmokers
Wang H, Huang Q, Xia J, Cheng S, Pei D, Zhang X, et al
et al (2007) Transport of buryryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+)
The IRE1 induces mRNA splicing and induces TNF-associated factor 2 (TRAF2), prompting inflammation/apoptosis (Rajapaksa et al., 2015)
Cosmetic weight loss and longevity: These medications are being marketed to people who do not meet medical criteria, including those who simply feel pressured to be thinner
A list including definitions of covariates is reported in Supplementary Table 1